AbbVie Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (170)

Latest Posts

About This Stock More About This Stock
Is AbbVie A Good Dividend Stock To Own In 2021?
Article By: StockNews
Wednesday, February 10, 2021 9:28 AM EST
Illinois-based pharmaceutical giant AbbVie Inc. has increased its dividend payout for nearly 49 consecutive years. The company’s dividend has grown at a CAGR of 22.8% over the past three years.
In this article: ABBV
Read
ABBV: A Safe 4.7% Yield In Biopharma
Article By: Marc Lichtenfeld
Wednesday, January 20, 2021 7:19 PM EST
Even with the slightly lower free cash flow total in 2019, AbbVie had more than enough to afford the $6.4 billion in dividends that it paid.
In this article: ABBV Also: ABT
Read
5 Top Healthcare Stocks For 2021
Article By: StockNews
Monday, January 18, 2021 10:38 AM EST
One market truism is that healthcare tends to outperform during Democratic administrations, while defense companies tend to do better under Republicans. Therefore, investors should consider healthcare stocks.
In this article: ABT, MDT, ZTS, ABBV, ANTM
Read
Report From J.P.Morgan Healthcare Conference 2021: Current Portfolio Positions #1
Article By: Rod Raynovich
Thursday, January 14, 2021 5:42 AM EST
The Conference boosted many stocks as you might expect in a bull market for biotech. We reviewed rather quickly some of the presentations from the JPMorgan Healthcare Conference and will comment on specific companies and stocks in a series of posts.
In this article: ABT, BMY, GNMK, IBB, HOLX, PACB, XBI, ABBV, AXDX, GKOS, TDOC, VIR Also: AZN, GSK, MRNA, BNTX, JPM
Read
4 Must-Own Dividend Stocks In 2021: AbbVie, Vale, Progressive, And HP
Article By: StockNews
Wednesday, December 30, 2020 7:23 AM EST
President Trump has signed a new stimulus bill which is good news for the markets going into 2021.
In this article: HPQ, PGR, VALE, ABBV
Read

Latest Tweets for $ABBV

No tweets yet!

$ABBV

5 Leading Healthcare Stocks Surging On Pent-up Demand
Craig Newman 11/11/2020 4:12:58 AM

Just a hunch. The healthcare industry is highly regulated and Dems generally favor more regulation, making it more difficult for drugmakers to secure the necessary regulatory approvals to market new products. Regulatory changes could drastically alter a healthcare stock’s growth prospects, for instance. But I reckon I'll not sell $ABBV after holding during all the long downward spiral.

5 Leading Healthcare Stocks Surging On Pent-up Demand
Craig Newman 11/10/2020 2:44:59 AM

Seems health stocks should do well but a #Biden presidency will not favor this sector. $ABBV $PFE

Macy’s Q1 Was Bad, But The Company Has The Cash To Survive The Current Pandemic
Jonathan Weber 7/3/2020 4:06:07 PM

Glad you liked it Sheryl! Right now I think a range of REITs and healthcare stocks are attractive from a risk-reward standpoint, including $ABBV, $BMY, $O, $SLG, $SPG, etc.

AbbVie: Is This Biopharma Giant’s 6% Yield Safe?
Beating Buffett 7/11/2019 1:00:14 PM

How much debt does $ABBV have?

AbbVie Has It All: Growth, Dividend Growth And Compelling Valuation
Dan Richards 6/25/2019 11:19:59 PM

$ABBV certainly sounds like a great buy.

AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug
Bruce Powers 1/23/2017 6:21:09 PM

Excited to hear the #FDA approved #IMBRUVICA. Should bode very well for $ABBV. And I think it's 8% price hike of #Humira is reasonable (though I realize those taking the drug may disagree).

1 to 6 of 6 comments